Retardation of metalloproteinase incidental to HIV and/or AIDS

Details Retardation of metalloproteinase incidental to HIV and/or AIDS Retardation of metalloproteinase incidental to HIV and/or AIDS

1997-04-29

2000-05-16

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

A61K 3165

Patent

active

060637757

ABSTRACT:
The instant invention provides a product of manufacture for retarding the biochemical formation of metalloproteinase, including gelatinase, elastase, collaginase, and the like, within the tissues of the body of a patient who has been inflicted with the HIV virus and/or the HIV virus which has advance to the AIDS virus, through the administration of an effective amount of a non-antimicrobial
on-antibiotic
on-antibacterial, chemically modified tetracycline (CMT) analog, its salts, cojugates and/or derivatives, and combinations thereof.

REFERENCES:
Lemaitre et al 112 CA 191459V, 1990.
Take et al 110 CA 147191M 1989.
Wondrak et al 108 CA: 179643K 1988.

Affiliated with

Also associated with

Rating

Retardation of metalloproteinase incidental to HIV and/or AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retardation of metalloproteinase incidental to HIV and/or AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retardation of metalloproteinase incidental to HIV and/or AIDS will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-259033